Sionna Therapeutics (SION) Assets Average (2025 - 2026)
Sionna Therapeutics' (SION) quarterly Assets Average came in at $315.5 million in Q1 2026, up 13.61% year-on-year from $277.7 million in Q1 2025, and down 5.15% quarter-over-quarter from $332.6 million in Q4 2025.
Sionna Therapeutics (SION) Assets Average (2025 - 2026) Analysis & Trends
Sionna Therapeutics has disclosed Assets Average across 2 years of filings, most recently posting $315.5 million for Q1 2026.
- Assets Average for Q1 2026 came in at $315.5 million, up 13.61% year-over-year; the trailing twelve-month figure through Mar 2026 was $315.5 million (up 13.61% YoY), and the FY2025 annual result was $255.9 million, changed N/A from the prior year.
- Assets Average came in at $315.5 million for Q1 2026 at Sionna Therapeutics, down from $332.6 million in the prior quarter.
- In the past five years, Assets Average ranged from a high of $360.9 million in Q2 2025 to a low of $277.7 million in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 860,679.92 Bn | 860,679.89 Bn | - | 33.42 Mn |
| 2 | Belite Bio | 55,284.00 Bn | 55,284.00 Bn | - | 795.91 Mn |
| 3 | Quantum Biopharma | 16,206.94 Bn | 16,206.93 Bn | - | 13.04 Mn |
| 4 | Legend Biotech | 3,318.00 Bn | 3,317.71 Bn | 242.10 Mn | 1.72 Bn |
| 5 | Akari Therapeutics | 1,543.84 Bn | 1,543.84 Bn | - | 40.89 Mn |
| 6 | Evaxion A | 1,449.11 Bn | 1,449.09 Bn | - | 26.03 Mn |
| 7 | Psyence Biomedical | 216.99 Bn | 216.98 Bn | - | 10.06 Mn |
| 8 | Vertex Pharmaceuticals | 115.22 Bn | 107.97 Bn | 2.59 Bn | 26.06 Bn |
| 9 | Abivax | 90.58 Bn | 90.58 Bn | - | 660.38 Mn |
| 10 | Sionna Therapeutics | 1.56 Bn | 1.56 Bn | - | 315.50 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 315.50 Mn |
| Dec 31, 2025 | 332.61 Mn |
| Sep 30, 2025 | 345.66 Mn |
| Jun 30, 2025 | 360.86 Mn |
| Mar 31, 2025 | 277.71 Mn |